Package 47781-564-01

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 47781-564-01
Digits Only 4778156401
Product NDC 47781-564
Product ID 47781-564_567bb281-4098-07f8-9503-92299dc1c4c6
Description

100 CAPSULE in 1 BOTTLE (47781-564-01)

Marketing

Marketing Status
Marketed Since 2023-08-25
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

lisdexamfetamine dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "567bb281-4098-07f8-9503-92299dc1c4c6", "openfda": {"upc": ["0347781568016", "0347781564018", "0347781567019", "0347781562014", "0347781563011", "0347781565015", "0347781566012"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["7f2dd6ee-3363-c87c-9693-ed838942556c"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (47781-564-01)", "package_ndc": "47781-564-01", "marketing_start_date": "20230825"}], "brand_name": "lisdexamfetamine dimesylate", "product_id": "47781-564_567bb281-4098-07f8-9503-92299dc1c4c6", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "47781-564", "dea_schedule": "CII", "generic_name": "lisdexamfetamine dimesylate", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lisdexamfetamine dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "ANDA214547", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}